Clinical trials
Phase 2 Ovarian Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
93 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2017 | 7 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 8 |
| 2021 | 10 |
| 2022 | 9 |
| 2023 | 8 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 93 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking Union Medical College Hospital | 4 |
| National Cancer Institute, Naples | 3 |
| Yonsei University | 3 |
| AltaRex | 2 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2 |
| Herbert Irving Comprehensive Cancer Center | 2 |
| Lei Li | 2 |
| Loyola University | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| Sun Yat-sen University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 93 |
| Carcinoma, Ovarian Epithelial | 23 |
| Fallopian Tube Neoplasms | 22 |
| Endometrial Neoplasms | 9 |
| Uterine Cervical Neoplasms | 9 |
| Recurrence | 5 |
| Sarcoma | 4 |
| Breast Neoplasms | 3 |
| Genital Neoplasms, Female | 3 |
| Neoplasms | 3 |
Trials
Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.